This Week in PLoS Medicine: IPTc for Malaria in children; Drug approval policies for Africa

Image Credit: Esther Simpson

Five new articles were published this week in PLoS Medicine, including three articles on ITPc for malaria and a Perspective on these pieces, as well as a Policy Forum on drug approval policies in Africa.

A randomized trial reported by Diadier Diallo and colleagues shows that intermittent preventive treatment for malaria in children who are protected from mosquitoes using insecticide-treated bednets provides substantial protection from malaria.

A randomized trial reported by Alassane Dicko and colleagues shows that intermittent preventive treatment for malaria in children who are protected from mosquitoes by insecticide-treated bednets provides substantial protection from malaria.

Kalifa Bojang and colleagues report a randomized trial showing that delivery of intermittent preventive treatment for malaria in children by village health workers is more effective than delivery by reproductive and child health trekking clinics.

Perspectives are articles commissioned from an expert that discuss the clinical practice or public health implications of a published study. This week James Beeson and colleagues discuss the three new studies in PLoS Medicine that provide valuable evidence on how to delivery and integrate intermittent preventive treatment for malaria in children (IPTc).

Mary Moran and colleagues discuss the best strategies for African regulators to be supported in their efforts to evaluate and approve drugs for their own populations.

Remember you can comment on, annotate and rate any PLoS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.

This entry was posted in General, PLoS Medicine Week by Week and tagged , , , . Bookmark the permalink.

Comments are closed.